α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review.
Alzheimer’s disease
Lipoic acid
Multiple sclerosis
Parkinson’s disease
Spinal cord injury
Stroke
Treatment
Journal
Nutritional neuroscience
ISSN: 1476-8305
Titre abrégé: Nutr Neurosci
Pays: England
ID NLM: 100892202
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
pubmed:
1
12
2017
medline:
2
5
2019
entrez:
30
11
2017
Statut:
ppublish
Résumé
α-lipoic acid (ALA) is a natural antioxidant which acts as a cofactor of bioenergetic mitochondrial enzymes. Along with its mitochondrial action, ALA and its reduced form have many biological functions resulting in a wide variety of actions such as anti-inflammation and antioxidant protection, scavenging reactive oxygen species, regenerating other antioxidant agents, such as vitamins C and E, and cytosolic glutathione, chelating the transitional metal ions (e.g. iron and copper), and modulating the signal transduction of nuclear factor. By selecting papers from PubMed, Science Direct, EBSCO, and databases, this review discusses the biochemical properties of LA, its mechanism of action, pharmacokinetics, and its possible therapeutic role in central nervous system diseases, such as Alzheimer's disease, Parkinson's disease, Multiple sclerosis, stroke, and spinal cord injury. ALA as an antioxidant and anti-inflammation agent has therapeutical effects on central nervous system diseases, especially multiple sclerosis and PD. ALA can be considered as a potentially useful treatment in central nervous disorders.
Identifiants
pubmed: 29185388
doi: 10.1080/1028415X.2017.1386755
doi:
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Antioxidants
0
Chelating Agents
0
Thioctic Acid
73Y7P0K73Y
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM